These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22789049)

  • 21. [Front line of combating counterfeit medicines, globally and locally].
    Kimura K
    Yakugaku Zasshi; 2014; 134(2):195-6. PubMed ID: 24492222
    [No Abstract]   [Full Text] [Related]  

  • 22. The joint interagency task force and the global steering committee for the quality assurance of health products: two new and proactive approaches promoting access to safe and effective medicines.
    Cinnamond M; Woods T
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):133-136. PubMed ID: 26041869
    [No Abstract]   [Full Text] [Related]  

  • 23. Understanding and fighting the medicine counterfeit market.
    Dégardin K; Roggo Y; Margot P
    J Pharm Biomed Anal; 2014 Jan; 87():167-75. PubMed ID: 23384475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of existing and emerging digital technologies to combat the global trade in fake medicines.
    Mackey TK; Nayyar G
    Expert Opin Drug Saf; 2017 May; 16(5):587-602. PubMed ID: 28349715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Counterfeit drug penetration into global legitimate medicine supply chains: a global assessment.
    Mackey TK; Liang BA; York P; Kubic T
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):59-67. PubMed ID: 25897059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Legislations combating counterfeit drugs in Hong Kong.
    Lai CW; Chan WK
    Hong Kong Med J; 2013 Aug; 19(4):286-93. PubMed ID: 23687210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of bilateral free trade agreements on access to medicines.
    Correa CM
    Bull World Health Organ; 2006 May; 84(5):399-404. PubMed ID: 16710551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The global counterfeit drug trade: patient safety and public health risks.
    Mackey TK; Liang BA
    J Pharm Sci; 2011 Nov; 100(11):4571-9. PubMed ID: 21698604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strengthening policies and structures to combat illicit tobacco trade in the Philippines.
    Arda JRY; Santiago AJA
    Front Public Health; 2023; 11():1089853. PubMed ID: 36761124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
    Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
    Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From cigarette smuggling to illicit tobacco trade.
    Joossens L; Raw M
    Tob Control; 2012 Mar; 21(2):230-4. PubMed ID: 22345257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Closing the door on illicit tobacco trade, opens the way to better tobacco control.
    Prasad V; Schwerdtfeger U; El-Awa F; Bettcher D; da Costa E Silva V
    East Mediterr Health J; 2015 Sep; 21(6):379-80. PubMed ID: 26369995
    [No Abstract]   [Full Text] [Related]  

  • 34. Why are generic drugs being held up in transit? Intellectual property rights, international trade, and the right to health in Brazil and beyond.
    Rosina MS; Shaver L
    J Law Med Ethics; 2012; 40(2):197-205. PubMed ID: 22789040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cautionary Notes on a Global Tiered Pricing Framework for Medicines.
    Williams OD; Ooms G; Hill PS
    Am J Public Health; 2015 Jul; 105(7):1290-3. PubMed ID: 25973806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmaceutical companies and global lack of access to medicines: strengthening accountability under the right to health.
    Grover A; Citro B; Mankad M; Lander F
    J Law Med Ethics; 2012; 40(2):234-50. PubMed ID: 22789043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International trade agreements challenge tobacco and alcohol control policies.
    Zeigler DW
    Drug Alcohol Rev; 2006 Nov; 25(6):567-79. PubMed ID: 17132574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Are there counterfeit medicines in Croatia?].
    Tomić S; Milcić N; Sokolić M; Sucić AF; Martinac AI
    Lijec Vjesn; 2010; 132(3-4):81-6. PubMed ID: 20540433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effects of Intellectual Property Rights on Access to Medicines and Catastrophic Expenditure.
    Jung Y; Kwon S
    Int J Health Serv; 2015; 45(3):507-29. PubMed ID: 26077858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of German official medicines control laboratories in combating counterfeit medicines].
    Wiegard A; Heuermann M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1214-1220. PubMed ID: 28948293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.